ISPC Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
iSpecimen Inc (ISPC) is not a good buy for a beginner investor with a long-term strategy at this moment. The company's financial performance is weak, with significant revenue decline and poor gross margins. Technical indicators are bearish, and there are no positive trading signals or catalysts to suggest an imminent recovery. The lack of news, options data, and congress trading activity further supports a cautious approach.
The technical indicators are bearish. The MACD is below 0 and negatively contracting, the RSI is neutral at 29.624, and the moving averages indicate a bearish trend (SMA_200 > SMA_20 > SMA_5). The stock is trading below key support levels, with a pivot at 0.257 and S1 at 0.145.
No positive catalysts identified. There is no recent news or significant trading activity from insiders, hedge funds, or congress members.
Significant revenue decline (-96.00% YoY), poor gross margin (-92.05%), and bearish technical indicators. The stock also has a low probability of significant short-term gains based on candlestick pattern analysis.
In Q3 2025, revenue dropped by 96.00% YoY to $106,592. Net income improved by 93.12% YoY but remains negative at -$2,780,648. EPS fell by 77.14% YoY to -0.48, and gross margin dropped significantly to -92.05%.
No analyst rating or price target changes available for this stock.
